HHLR Advisors, Ltd. 13D and 13G filings for Apellis Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2022-02-14 4:04 pm Sale |
2021-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
HHLR Advisors, Ltd. | 0 0.000% |
-5,028,289 (Position Closed) |
Filing |
| 2021-02-16 4:09 pm Purchase |
2020-12-31 | 13G | Apellis Pharmaceuticals, Inc. APLS |
HHLR Advisors, Ltd. | 5,028,289 6.600% |
350,000 (+7.48%) |
Filing |